Kidney International,
Journal Year:
2020,
Volume and Issue:
97(6), P. 1230 - 1242
Published: Feb. 17, 2020
Chronic
kidney
disease
(CKD)
is
characterized
by
accumulation
of
protein-bound
uremic
toxins
such
as
p-cresyl
sulfate,
glucuronide,
indoxyl
sulfate
and
indole-3-acetic
acid,
which
originate
in
the
gut.
Intestinal
bacteria
metabolize
aromatic
amino
acids
into
p-cresol
indole,
(further
conjugated
colon
mucosa
liver)
acid.
Here
we
measured
fecal,
plasma
urine
metabolite
concentrations;
contribution
gut
bacterial
generation
to
accumulation;
influx
circulating
at
different
stages
CKD.
Feces,
blood
were
collected
from
14
control
individuals
141
patients
with
Solutes
quantified
ultra-high
performance
liquid
chromatography.
To
assess
rate
p-cresol,
indole
fecal
samples
cultured
ex
vivo.
With
CKD
progression,
an
increase
levels
was
observed
plasma,
whereas
these
their
precursors
remained
same
feces
urine.
Anaerobic
culture
showed
no
difference
vivo
acid
generation.
Therefore,
differences
between
cannot
be
explained
rates
gut,
suggesting
retention
due
impaired
function
main
contributor
increased
levels.
Thus,
fractional
clearance
decreased
progression
CKD,
tubular
appeared
more
affected
than
glomerular
filtration
rate,
there
net
lumen
Toxins,
Journal Year:
2018,
Volume and Issue:
10(1), P. 33 - 33
Published: Jan. 8, 2018
In
this
narrative
review,
the
biological/biochemical
impact
(toxicity)
of
a
large
array
known
individual
uremic
retention
solutes
and
groups
is
summarized.
We
classified
these
compounds
along
their
physico-chemical
characteristics
as
small
water-soluble
or
groups,
protein
bound
middle
molecules.
All
but
one
solute
(glomerulopressin)
affected
at
least
mechanism
with
potential
to
contribute
syndrome.
general,
several
mechanisms
were
influenced
for
each
group
solutes,
some
impacting
up
7
different
biological
systems
11
considered.
The
inflammatory,
cardio-vascular
fibrogenic
those
most
frequently
they
are
by
major
actors
in
high
morbidity
mortality
CKD
also
that
have
been
studied.
A
scoring
system
was
built
intention
classify
reviewed
according
experimental
evidence
toxicity
(number
affected)
overall
clinical
evidence.
Among
highest
globally
3
[asymmetric
dimethylarginine
(ADMA);
trimethylamine-N-oxide
(TMAO);
uric
acid],
6
[advanced
glycation
end
products
(AGEs);
p-cresyl
sulfate;
indoxyl
indole
acetic
acid;
kynurenines;
phenyl
acid;]
molecules
[β2-microglobulin;
ghrelin;
parathyroid
hormone).
more
data
provided
almost
half
them
missing
spite
robust
data.
picture
emanating
complex
disorder,
where
multiple
factors
multisystem
complication
profile,
so
it
seems
not
much
use
pursue
decrease
concentration
single
compound.
AJP Renal Physiology,
Journal Year:
2016,
Volume and Issue:
310(9), P. F857 - F871
Published: Feb. 11, 2016
Patients
and
animals
with
chronic
kidney
disease
(CKD)
exhibit
profound
alterations
in
the
gut
environment
including
shifts
microbial
composition,
increased
fecal
pH,
blood
levels
of
microbe-derived
metabolites
(xenometabolites).
The
fermentable
dietary
fiber
high
amylose
maize-resistant
starch
type
2
(HAMRS2)
has
been
shown
to
alter
milieu
CKD
rat
models
leads
markedly
improved
function.
aim
present
study
was
identify
specific
cecal
bacteria
cecal,
blood,
urinary
that
associate
changes
function
potential
mechanisms
involved
amelioration
response
resistant
starch.
Male
Sprague-Dawley
rats
adenine-induced
were
fed
a
semipurified
low-fiber
diet
or
high-fiber
[59%
(wt/wt)
HAMRS2]
for
3
wk
(n
=
9
rats/group).
microbiome
characterized,
contents,
serum,
urine
analyzed.
HAMRS2-fed
displayed
decreased
diversity,
an
Bacteroidetes-to-Firmicutes
ratio.
Several
uremic
retention
solutes
altered
urine,
many
which
had
strong
correlations
abundances,
i.e.,
serum
indoxyl
sulfate
reduced
by
36%
66%,
respectively,
p-cresol
47%
rats.
Outcomes
from
this
coincident
improvements
indexes
outcomes
previously
reported
these
rats,
suggesting
important
role
microbial-derived
factors
microbe
metabolism
regulating
host
Nutrients,
Journal Year:
2017,
Volume and Issue:
9(3), P. 208 - 208
Published: Feb. 27, 2017
Elevated
protein
catabolism
and
malnutrition
are
common
in
patients
with
chronic
kidney
disease
(CKD)
end‐stage
renal
(ESRD).
The
underlying
etiology
includes,
but
is
not
limited
to,
metabolic
acidosis
intestinal
dysbiosis;
systemic
inflammation
activation
of
complements,
endothelin‐1
renin‐angiotensin‐aldosterone
(RAAS)
axis;
anabolic
hormone
resistance;
energy
expenditure
elevation;
uremic
toxin
accumulation.
All
these
derangements
can
further
worsen
function,
leading
to
poor
patient
outcomes.
Many
CKD‐related
be
prevented
substantially
reversed,
representing
an
area
great
potential
improve
CKD
ESRD
care.
This
review
integrates
known
information
recent
advances
the
nutrition
ESRD.
Management
recommendations
summarized.
Thorough
understanding
pathogenesis
will
undoubtedly
facilitate
design
development
more
effective
strategies
optimize
Toxins,
Journal Year:
2021,
Volume and Issue:
13(2), P. 142 - 142
Published: Feb. 13, 2021
Chronic
kidney
disease
(CKD)
is
a
progressive
loss
of
renal
function.
The
gradual
decline
in
function
leads
to
an
accumulation
toxins
normally
cleared
by
the
kidneys,
resulting
uremia.
Uremic
are
classified
into
three
categories:
free
water-soluble
low-molecular-weight
solutes,
protein-bound
and
middle
molecules.
CKD
patients
have
increased
risk
developing
cardiovascular
(CVD),
due
assortment
CKD-specific
factors.
uremic
circulation
tissues
associated
with
progression
its
co-morbidities,
including
CVD.
Although
numerous
been
identified
date
many
them
believed
play
role
CVD,
very
few
extensively
studied.
pathophysiological
mechanisms
must
be
investigated
further
for
better
understanding
their
roles
develop
therapeutic
interventions
against
toxicity.
This
review
discusses
toxicity
indoxyl
sulfate,
p-cresyl
hippuric
acid,
TMAO,
ADMA,
TNF-α,
IL-6.
A
focus
also
placed
on
potential
targets
It
is
now
convincingly
clear
that
diet
one
of
the
most
influential
lifestyle
factors
contributing
to
rise
inflammatory
diseases
and
autoimmunity
in
both
developed
developing
countries.
In
addition,
modern
'Western
diet'
has
changed
recent
years
with
increased
caloric
intake,
changes
relative
amounts
dietary
components,
including
lower
fibre
higher
levels
fat
poor
quality
carbohydrates.
Diet
shapes
large‐bowel
microbial
ecology,
this
may
be
highly
relevant
human
diseases,
as
gut
microbiota
composition
are
associated
many
diseases.
Recent
studies
have
demonstrated
a
remarkable
role
for
diet,
their
metabolites—the
short‐chain
fatty
acids
(SCFAs)—in
pathogenesis
several
such
asthma,
arthritis,
bowel
disease,
colon
cancer
wound‐healing.
This
review
summarizes
how
metabolites
(particularly
SCFAs)
can
modulate
progression
autoimmunity,
reveal
molecular
mechanisms
(metabolite‐sensing
G
protein‐coupled
receptor
(GPCRs)
inhibition
histone
deacetylases
(HDACs)).
Therefore,
considerable
benefit
could
achieved
simply
through
use
probiotics
prevention
treatment
autoimmunity.
Letters in Applied Microbiology,
Journal Year:
2020,
Volume and Issue:
72(6), P. 636 - 668
Published: May 30, 2020
Human
gut
microbiota
(GM)
includes
a
complex
and
dynamic
population
of
microorganisms
that
are
crucial
for
well‐being
survival
the
organism.
It
has
been
reported
as
diverse
relatively
stable
with
shared
core
microbiota,
including
Bacteroidetes
Firmicutes
major
dominants.
They
key
regulators
body
homeostasis,
involving
both
intestinal
extra‐intestinal
effects
by
influencing
many
physiological
functions
such
metabolism,
maintenance
barrier
inflammation
hematopoiesis.
Any
alteration
in
GM
community
structures
not
only
trigger
disorders
but
also
influence
other
organs
cause
associated
diseases.
In
recent
past,
defined
'vital
organ'
its
involvement
organs;
thus,
establishing
link
or
bi‐
multidirectional
communication
axis
between
via
neural,
endocrine,
immune,
humoral
metabolic
pathways.
Alterations
have
linked
to
several
diseases
known
humans;
although
exact
interaction
mechanism
is
yet
be
defined.
this
review,
bidirectional
relationship
vital
human
was
envisaged
discussed
under
headings.
Furthermore,
disease
symptoms
were
revisited
redefine
network
microbes
organs.
Significance
Impact
Study:
Gut
metabolites
play
role
maintaining
health
various
Literature
review
evidences
suggest
any
composition
diversity
triggers
influences
cause‐associated
we
attempted
provide
readers
broad
overview
connection
Our
effort
will
foster
development
personalized
treatment
can
adopted
evolved
targeting
microbiome
deliberately
controlled
manner.
Kidney International,
Journal Year:
2017,
Volume and Issue:
92(3), P. 634 - 645
Published: April 8, 2017
Gut
microbiota
is
involved
in
the
metabolism
of
uremic
solutes.
However,
precise
influence
to
retention
solutes
CKD
obscure.
To
clarify
this,
we
compared
adenine-induced
renal
failure
and
control
mice
under
germ-free
or
specific
pathogen-free
(SPF)
conditions,
examining
metabolite
profiles
plasma,
feces,
urine
using
a
capillary
electrophoresis
time-of-flight
mass
spectrometry-based
approach.
Mice
with
conditions
demonstrated
significant
changes
plasma
metabolites.
Among
183
detected
solutes,
levels
11
including
major
toxins,
were
significantly
lower
than
SPF
failure.
These
considered
microbiota-derived
included
indoxyl
sulfate,
p-cresyl
phenyl
cholate,
hippurate,
dimethylglycine,
γ-guanidinobutyrate,
glutarate,
2-hydroxypentanoate,
trimethylamine
N-oxide,
phenaceturate.
Metabolome
profiling
showed
that
these
classified
into
three
groups
depending
on
their
origins:
completely
derived
from
(indoxyl
sulfate),
both
host
(dimethylglycine),
dietary
components
(trimethylamine
N-oxide).
Additionally,
resulted
disappearance
colonic
short-chain
fatty
acids,
decreased
utilization
intestinal
amino
more
severe
damage
Microbiota-derived
acids
efficient
acid
may
have
renoprotective
effect,
loss
factors
exacerbate
Thus,
contributes
substantially
production
harmful
but
conversely,
growth
without
has
effects
progression.